Goldman Sachs Group Inc. Sells 1,250,361 Shares of Karyopharm Therapeutics Inc. $KPTI
MarketBeat
Goldman Sachs Group Inc. cut its stake in shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI - Free Report) by 93.6% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 85,410 shares of the company's stock after selling 1,250,361 shares during the period. Gol
NASDAQ:KPTI